NYSE : BMY
Bristol-Myers Squibb Company — Financial statements
Healthcare · Drug Manufacturers - General · United States
Last price 62.48 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 127.71B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Bristol-Myers Squibb Company (BMY) reported revenue of 50.03B USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 50.03B | 48.19B | 48.30B | 45.01B | 46.16B | 46.38B |
| Cost of Revenue | 14.76B | 13.19B | 11.95B | 10.63B | 10.14B | 9.94B |
| Gross Profit | 35.27B | 35.00B | 36.35B | 34.38B | 36.02B | 36.45B |
| Selling, General & Admin | 7.23B | 7.15B | 7.87B | 7.68B | 7.78B | 7.66B |
| Research & Development | 9.70B | 9.49B | 9.78B | 9.29B | 9.51B | 10.20B |
| Amortization of Goodwill & Intangibles | 2.16B | 3.32B | 8.87B | 9.05B | 9.60B | 10.02B |
| Operating Expenses | 19.08B | 19.96B | 26.52B | 26.01B | 26.88B | 27.87B |
| Operating Income | 16.19B | 15.04B | 9.83B | 8.37B | 9.14B | 8.57B |
| Interest Expense | -1.64B | -1.89B | -1.96B | -1.16B | -1.21B | -1.30B |
| Interest & Investment Income | 471.00M | 586.00M | 478.00M | 449.00M | 171.00M | 39.00M |
| Earnings From Equity Investments | 47.00M | 47.00M | 44.00M | -38.00M | -108.00M | 231.00M |
| Currency Exchange Gain (Loss) | 11.00M | 92.00M | 31.00M | 160.00M | 148.00M | 32.00M |
| Other Non Operating Income (Expenses) | 1.21B | 2.12B | 1.48B | 2.12B | 1.83B | 1.71B |
| EBT Excluding Unusual Items | 16.30B | 16.00B | 9.91B | 9.89B | 9.97B | 9.28B |
| Merger & Restructuring Charges | -662.00M | -1.09B | -1.97B | -809.00M | -520.00M | -724.00M |
| Gain (Loss) on Sale of Investments | 365.00M | 233.00M | -28.00M | -122.00M | -693.00M | 514.00M |
| Gain (Loss) on Sale of Assets | 162.00M | -1.00M | -15.00M | 211.00M | 9.00M | |
| Asset Writedown | -1.39B | -949.00M | -2.82B | |||
| Legal Settlements | -21.00M | -434.00M | -84.00M | -10.00M | -178.00M | -82.00M |
| Other Unusual Items | -371.00M | -707.00M | 400.00M | -266.00M | 261.00M | |
| Pretax Income | 11.33B | 9.33B | -8.38B | 8.44B | 7.71B | 8.10B |
| Income Tax Expense | 2.09B | 2.27B | 554.00M | 400.00M | 1.37B | 1.08B |
| Earnings From Continuing Operations | 9.24B | 7.06B | -8.93B | 8.04B | 6.34B | 7.01B |
| Minority Interest in Earnings | 1.00M | -2.00M | -15.00M | -15.00M | -18.00M | -20.00M |
| Net Income | 9.24B | 7.05B | -8.95B | 8.03B | 6.33B | 6.99B |
| Net Income to Common | 9.24B | 7.05B | -8.95B | 8.03B | 6.33B | 6.99B |
| Shares Outstanding (Basic) | 2.04B | 2.03B | 2.03B | 2.07B | 2.13B | 2.22B |
| Shares Outstanding (Diluted) | 2.05B | 2.04B | 2.03B | 2.08B | 2.15B | 2.25B |
| EPS (Basic) | 4.53 | 3.47 | -4.41 | 3.88 | 2.97 | 3.15 |
| EPS (Diluted) | 4.51 | 3.46 | -4.41 | 3.86 | 2.95 | 3.12 |
| Free Cash Flow | 9.29B | 12.85B | 13.94B | 12.65B | 11.95B | 15.23B |
| Free Cash Flow Per Share | 4.54 | 6.30 | 6.88 | 6.09 | 5.57 | 6.79 |
| Dividend Per Share | 2.52 | 2.49 | 2.42 | 2.31 | 2.19 | 2.01 |
| Gross Margin | 70.50% | 72.62% | 75.26% | 76.38% | 78.04% | 78.57% |
| Operating Margin | 32.37% | 31.20% | 20.36% | 18.59% | 19.80% | 18.48% |
| Profit Margin | 18.47% | 14.64% | -18.53% | 17.83% | 13.71% | 15.08% |
| Free Cash Flow Margin | 18.56% | 26.65% | 28.87% | 28.11% | 25.88% | 32.84% |
| EBITDA | 18.24B | 19.12B | 19.41B | 18.13B | 19.42B | 19.33B |
| EBITDA Margin | 36.46% | 39.66% | 40.18% | 40.29% | 42.08% | 41.67% |
| D&A For EBITDA | 2.05B | 4.08B | 9.57B | 9.77B | 10.28B | 10.76B |
| EBIT | 16.19B | 15.04B | 9.83B | 8.37B | 9.14B | 8.57B |
| EBIT Margin | 32.37% | 31.20% | 20.36% | 18.59% | 19.80% | 18.48% |
| Effective Tax Rate | 18.44% | 24.36% | 4.74% | 17.74% | 13.39% | |
| Revenue as Reported | 50.03B | 48.19B | 48.30B | 45.01B | 46.16B | 46.38B |
| Advertising Expenses | 1.30B | 1.30B |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 9.57B | 10.21B | 10.35B | 11.46B | 9.12B | 13.98B |
| Short-Term Investments | 3.01B | 464.00M | 513.00M | 816.00M | 130.00M | 3.24B |
| Cash & Short-Term Investments | 12.58B | 10.67B | 10.86B | 12.28B | 9.25B | 17.22B |
| Accounts Receivable | 10.72B | 11.61B | 11.13B | 11.34B | 10.39B | 9.73B |
| Other Receivables | 2.13B | 2.92B | 3.29B | 3.93B | 3.55B | 2.79B |
| Receivables | 12.85B | 14.53B | 14.42B | 15.26B | 13.94B | 12.52B |
| Inventory | 2.70B | 2.69B | 2.56B | 2.66B | 2.34B | 2.10B |
| Restricted Cash | 55.00M | 148.00M | 140.00M | |||
| Other Current Assets | 1.63B | 1.50B | 1.94B | 1.51B | 1.60B | 1.29B |
| Total Current Assets | 29.77B | 29.39B | 29.78B | 31.77B | 27.27B | 33.26B |
| Property, Plant & Equipment | 9.45B | 9.12B | 8.36B | 8.04B | 7.47B | 6.97B |
| Long-Term Investments | 2.32B | 2.49B | 2.06B | 2.06B | 2.19B | 2.71B |
| Goodwill | 21.73B | 21.75B | 21.72B | 21.17B | 21.15B | 20.50B |
| Other Intangible Assets | 16.94B | 19.10B | 23.31B | 27.07B | 35.86B | 42.53B |
| Long-Term Deferred Tax Assets | 5.88B | 5.38B | 4.24B | 2.77B | 1.34B | 1.44B |
| Long-Term Deferred Charges | 230.00M | 250.00M | 336.00M | 413.00M | 496.00M | 248.00M |
| Other Long-Term Assets | 2.45B | 2.55B | 2.81B | 1.87B | 1.04B | 1.66B |
| Total Assets | 88.77B | 90.04B | 92.60B | 95.16B | 96.82B | 109.31B |
| Accounts Payable | 4.63B | 3.58B | 3.60B | 3.26B | 3.04B | 2.95B |
| Accrued Expenses | 8.98B | 12.86B | 13.13B | 11.04B | 10.24B | 9.94B |
| Short-Term Debt | 260.00M | 284.00M | 218.00M | 246.00M | 367.00M | 184.00M |
| Current Portion of Long-Term Debt | 768.00M | 1.98B | 1.83B | 2.87B | 3.90B | 4.76B |
| Current Portion of Leases | 220.00M | 202.00M | 181.00M | 162.00M | 136.00M | 169.00M |
| Current Income Taxes Payable | 727.00M | 979.00M | 1.51B | 1.37B | 942.00M | 754.00M |
| Other Current Liabilities | 3.17B | 3.54B | 3.30B | 3.31B | 3.27B | 3.11B |
| Total Current Liabilities | 18.75B | 23.42B | 23.77B | 22.26B | 21.89B | 21.87B |
| Long-Term Debt | 41.85B | 42.90B | 47.64B | 36.70B | 35.16B | 39.60B |
| Long-Term Leases | 1.71B | 1.83B | 1.37B | 1.53B | 1.26B | 874.00M |
| Long-Term Unearned Revenue | 128.00M | 169.00M | 230.00M | 300.00M | 283.00M | 326.00M |
| Pension & Post-Retirement Benefits | 299.00M | 330.00M | 400.00M | 480.00M | 402.00M | 654.00M |
| Long-Term Deferred Tax Liabilities | 228.00M | 222.00M | 369.00M | 338.00M | 2.17B | 4.50B |
| Other Long-Term Liabilities | 2.40B | 2.67B | 2.43B | 4.07B | 4.54B | 5.48B |
| Total Liabilities | 65.37B | 71.53B | 76.22B | 65.67B | 65.70B | 73.31B |
| Common Stock | 292.00M | 292.00M | 292.00M | 292.00M | 292.00M | 292.00M |
| Additional Paid-In Capital | 46.67B | 46.39B | 46.02B | 45.68B | 45.16B | 44.36B |
| Retained Earnings | 21.19B | 16.90B | 14.91B | 28.77B | 25.50B | 23.82B |
| Treasury Stock | -43.47B | -43.58B | -43.66B | -43.77B | -38.62B | -31.26B |
| Comprehensive Income & Other | -1.28B | -1.52B | -1.24B | -1.55B | -1.28B | -1.27B |
| Total Common Equity | 23.40B | 18.47B | 16.34B | 29.43B | 31.06B | 35.95B |
| Minority Interest | 33.00M | 53.00M | 55.00M | 57.00M | 60.00M | |
| Shareholders' Equity | 23.40B | 18.51B | 16.39B | 29.48B | 31.12B | 36.01B |
| Total Liabilities & Equity | 88.77B | 90.04B | 92.60B | 95.16B | 96.82B | 109.31B |
| Total Debt | 44.81B | 47.19B | 51.24B | 41.51B | 40.82B | 45.60B |
| Net Cash (Debt) | -31.85B | -36.12B | -40.06B | -28.86B | -31.57B | -28.38B |
| Net Cash Per Share | -15.56 | -17.71 | -19.76 | -13.89 | -14.71 | -12.64 |
| Filing Date Shares Outstanding | 2.04B | 2.04B | 2.03B | 2.02B | 2.10B | 2.18B |
| Total Common Shares Outstanding | 2.04B | 2.04B | 2.03B | 2.02B | 2.10B | 2.18B |
| Working Capital | 11.01B | 5.97B | 6.01B | 9.51B | 5.38B | 11.39B |
| Book Value Per Share | 11.45 | 9.07 | 8.05 | 14.56 | 14.81 | 16.52 |
| Tangible Book Value | -15.27B | -22.38B | -28.69B | -18.81B | -25.95B | -27.08B |
| Tangible Book Value Per Share | -7.47 | -10.99 | -14.14 | -9.31 | -12.37 | -12.45 |
| Land | 164.00M | 157.00M | 161.00M | 162.00M | 162.00M | 169.00M |
| Buildings | 7.97B | 7.27B | 6.58B | 6.50B | 5.92B | 5.90B |
| Machinery | 4.04B | 3.79B | 3.82B | 3.72B | 3.28B | 3.25B |
| Construction In Progress | 1.48B | 1.62B | 1.52B | 1.07B | 1.05B | 764.00M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 9.24B | 7.05B | -8.95B | 8.03B | 6.33B | 6.99B |
| Depreciation & Amortization | 2.05B | 4.08B | 9.57B | 9.77B | 10.28B | 10.76B |
| Loss (Gain) From Sale of Assets | -186.00M | -36.00M | -15.00M | -22.00M | -231.00M | -18.00M |
| Asset Writedown & Restructuring Costs | 4.47B | 4.86B | 16.41B | 1.21B | 999.00M | 2.37B |
| Loss (Gain) From Sale of Investments | -412.00M | -280.00M | -16.00M | 160.00M | 801.00M | -745.00M |
| Stock-Based Compensation | 552.00M | 553.00M | 507.00M | 518.00M | 457.00M | 583.00M |
| Other Operating Activities | -146.00M | -1.62B | -3.13B | -3.89B | -3.34B | -2.47B |
| Change in Accounts Receivable | 428.00M | -295.00M | 264.00M | -995.00M | -663.00M | -1.05B |
| Change in Inventory | 182.00M | -184.00M | -486.00M | -751.00M | -69.00M | 13.00M |
| Change in Accounts Payable | 542.00M | -2.00M | 184.00M | 198.00M | 109.00M | 245.00M |
| Change in Income Taxes | -464.00M | -4.00M | -1.26B | -603.00M | -1.42B | -1.06B |
| Change in Other Net Operating Assets | -5.61B | 30.00M | 2.11B | 237.00M | -183.00M | 598.00M |
| Operating Cash Flow | 10.65B | 14.16B | 15.19B | 13.86B | 13.07B | 16.21B |
| Capital Expenditures | -1.37B | -1.31B | -1.25B | -1.21B | -1.12B | -973.00M |
| Cash Acquisitions | -2.98B | -3.94B | -21.82B | -1.17B | -4.29B | -1.61B |
| Divestitures | 791.00M | 1.07B | 1.10B | 909.00M | 1.30B | 748.00M |
| Investment in Securities | -1.76B | 52.00M | 618.00M | -826.00M | 3.04B | 1.30B |
| Investing Cash Flow | -5.31B | -4.13B | -21.35B | -2.29B | -1.06B | -538.00M |
| Short-Term Debt Issued | 25.00M | 3.09B | 194.00M | |||
| Long-Term Debt Issued | 5.74B | 12.88B | 4.46B | 5.93B | ||
| Total Debt Issued | 5.52B | 5.76B | 15.97B | 4.46B | 6.12B | |
| Short-Term Debt Repaid | -3.00B | -120.00M | -160.00M | |||
| Long-Term Debt Repaid | -10.94B | -2.87B | -3.88B | -11.43B | -6.02B | |
| Total Debt Repaid | -11.79B | -10.94B | -5.87B | -4.00B | -11.43B | -6.18B |
| Net Debt Issued (Repaid) | -6.26B | -5.17B | 10.10B | 456.00M | -5.31B | -6.18B |
| Issuance of Common Stock | 27.00M | 984.00M | ||||
| Repurchase of Common Stock | -5.16B | -8.00B | -6.29B | |||
| Common Dividends Paid | -5.12B | -5.04B | -4.86B | -4.74B | -4.63B | -4.40B |
| Other Financing Activities | -58.00M | -128.00M | -106.00M | 641.00M | ||
| Financing Cash Flow | -11.44B | -10.35B | 5.13B | -9.42B | -16.96B | -16.22B |
| Foreign Exchange Rate Adjustments | -56.00M | 195.00M | -137.00M | 45.00M | -33.00M | -102.00M |
| Net Cash Flow | -6.15B | -129.00M | -1.17B | 2.19B | -4.99B | -657.00M |
| Free Cash Flow | 9.29B | 12.85B | 13.94B | 12.65B | 11.95B | 15.23B |
| Free Cash Flow Margin | 18.56% | 26.65% | 28.87% | 28.11% | 25.88% | 32.84% |
| Free Cash Flow Per Share | 4.54 | 6.30 | 6.88 | 6.09 | 5.57 | 6.79 |
| Levered Free Cash Flow | 6.36B | 11.15B | 16.89B | 13.60B | 13.34B | 12.79B |
| Unlevered Free Cash Flow | 7.39B | 12.33B | 18.11B | 14.33B | 14.09B | 13.60B |
| Cash Interest Paid | 1.70B | 2.10B | 1.80B | 1.20B | 1.40B | 1.50B |
| Cash Income Tax Paid | 4.06B | 3.26B | 3.90B | 4.30B | 5.40B | 3.50B |
| Change in Working Capital | -4.92B | -455.00M | 810.00M | -1.91B | -2.23B | -1.26B |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 127.71B | 109.81B | 114.71B | 104.40B | 159.70B | 138.39B |
| Enterprise Value | 159.57B | 143.99B | 157.79B | 135.78B | 190.91B | 168.44B |
| Last Close Price | 62.48 | 51.64 | 51.59 | 44.55 | 60.31 | 50.69 |
| PE Ratio | 13.84 | 15.57 | 13.01 | 25.24 | 19.79 | |
| Forward PE | 9.72 | 8.73 | 7.96 | 6.85 | 9.26 | 8.00 |
| PS Ratio | 2.55 | 2.28 | 2.38 | 2.32 | 3.46 | 2.98 |
| PB Ratio | 5.46 | 5.93 | 7.00 | 3.54 | 5.13 | 3.84 |
| P/FCF Ratio | 13.75 | 8.55 | 8.23 | 8.25 | 13.37 | 9.09 |
| P/OCF Ratio | 11.99 | 7.76 | 7.55 | 7.53 | 12.22 | 8.54 |
| PEG Ratio | 0.10 | 0.77 | 37.97 | 3.55 | 2.31 | |
| EV/Sales Ratio | 3.19 | 2.99 | 3.27 | 3.02 | 4.14 | 3.63 |
| EV/EBITDA Ratio | 8.75 | 7.53 | 8.13 | 7.49 | 9.83 | 8.71 |
| EV/EBIT Ratio | 9.85 | 9.57 | 16.05 | 16.23 | 20.89 | 19.65 |
| EV/FCF Ratio | 17.18 | 11.21 | 11.32 | 10.73 | 15.98 | 11.06 |
| Debt / Equity Ratio | 1.92 | 2.55 | 3.13 | 1.41 | 1.31 | 1.27 |
| Debt / EBITDA Ratio | 2.41 | 2.43 | 2.59 | 2.24 | 2.07 | 2.33 |
| Debt / FCF Ratio | 4.83 | 3.67 | 3.67 | 3.28 | 3.42 | 2.99 |
| Net Debt / Equity Ratio | 1.36 | 1.95 | 2.44 | 0.98 | 1.01 | 0.79 |
| Net Debt / EBITDA Ratio | 1.75 | 1.89 | 2.06 | 1.59 | 1.62 | 1.47 |
| Net Debt / FCF Ratio | 3.43 | 2.81 | 2.87 | 2.28 | 2.64 | 1.86 |
| Asset Turnover | 0.54 | 0.53 | 0.51 | 0.47 | 0.45 | 0.41 |
| Inventory Turnover | 5.40 | 5.03 | 4.58 | 4.25 | 4.57 | 4.77 |
| Quick Ratio | 1.36 | 1.08 | 1.06 | 1.24 | 1.06 | 1.36 |
| Current Ratio | 1.59 | 1.25 | 1.25 | 1.43 | 1.25 | 1.52 |
| Return on Equity (ROE) | 44.01% | 40.44% | -38.95% | 26.53% | 18.91% | 18.98% |
| Return on Assets (ROA) | 10.90% | 10.29% | 6.55% | 5.45% | 5.54% | 4.70% |
| Return on Invested Capital (ROIC) | 23.60% | 20.35% | 17.03% | 13.13% | 11.84% | 10.80% |
| Return on Capital Employed (ROCE) | 23.10% | 22.60% | 14.30% | 11.50% | 12.20% | 9.80% |
| Earnings Yield | 7.22% | 6.42% | -7.80% | 7.69% | 3.96% | 5.05% |
| FCF Yield | 7.27% | 11.70% | 12.15% | 12.12% | 7.48% | 11.01% |
| Dividend Yield | 4.03% | 4.62% | 4.28% | 4.47% | 2.88% | 3.16% |
| Payout Ratio | 55.84% | 71.52% | 59.11% | 73.24% | 62.85% | |
| Buyback Yield / Dilution | -0.48% | -0.59% | 2.45% | 3.17% | 4.41% | 0.58% |
| Total Shareholder Return | 3.55% | 4.03% | 6.73% | 7.64% | 7.29% | 3.74% |